Randomized comparison of six versus twenty-four months clopidogrel therapy after balancing anti-intimal hyperplasia stent potency in all comer patients undergoing percutaneous coronary intervention. Results of the PRODIGY Trial

Randomized comparison of six versus twenty-four months clopidogrel therapy after balancing anti-intimal hyperplasia stent potency in all comer patients undergoing percutaneous coronary intervention. Results of the PRODIGY Trial

Bibliographic Details
Main Author:	Vijayakumar Subban
Format:	Article
Language:	English
Published:	Elsevier 2012-07-01
Series:	Indian Heart Journal
Online Access:	http://www.sciencedirect.com/science/article/pii/S0019483212000557

Similar Items

Comparison of Ticagrelor and Clopidogrel for Patients Undergoing Emergency Percutaneous Coronary Intervention
by: Bin YANG, et al.
Published: (2018-07-01)

Six months outcome in patients undergoing percutaneous coronary intervention for true bifurcation lesions without side branch stenting
by: Rahul Subhashrao Chalwade, et al.
Published: (2018-01-01)

Prodigy Interim Report
by: Ian Purves, et al.
Published: (1996-09-01)

Prodigious plant methylomes
by: Gehring, Mary
Published: (2018)

Comparison of prasugrel and clopidogrel in patients with acute coronary syndrome undergoing percutaneous coronary intervention
by: Nicholas B Norgard, et al.
Published: (2009-10-01)

RESISTANCE TO ANTIPLATELET DRUGS (ASPIRIN, CLOPIDOGREL) IN PATIENTS UNDERGOING ELECTIVE PERCUTANEOUS CORONARY INTERVENTION
by: V. A. Sulimov, et al.
Published: (2015-12-01)

RESISTANCE TO ANTIPLATELET DRUGS (ASPIRIN, CLOPIDOGREL) IN PATIENTS UNDERGOING ELECTIVE PERCUTANEOUS CORONARY INTERVENTION
by: V. A. Sulimov, et al.
Published: (2015-12-01)

What Makes Musical Prodigies?
by: Chanel Marion-St-Onge, et al.
Published: (2020-12-01)

Giants and prodigies in Spanish literature
by: Adrián Sáez García
Published: (2010-11-01)

Neointimal hyperplasia persists at six months after sirolimus-eluting stent implantation in diabetic porcine
by: Yang ZhenKun, et al.
Published: (2007-06-01)

12-Month clinical outcomes of amphilimus drug eluting stents in an all-comers South-East Asian registry
by: Hee Hwa Ho, et al.
Published: (2020-02-01)

12-Month clinical outcomes of amphilimus drug eluting stents in an all-comers South-East Asian registry
by: Arshad, M.K.M, et al.
Published: (2020)

Comparison of Clopidogrel and Ticlopidine/Ginkgo Biloba in Patients With Clopidogrel Resistance and Carotid Stenting
by: Jong-Won Chung, et al.
Published: (2019-01-01)

Effects of Ticagrelor versus Clopidogrel in Patients with Coronary Bifurcation Lesions Undergoing Percutaneous Coronary Intervention
by: Wei Zheng, et al.
Published: (2019-01-01)

Zero contrast optical coherence tomography–guided percutaneous coronary intervention for in-stent restenosis of the saphenous vein graft using a non-contrast flush medium
by: Nandhakumar Vasu, et al.
Published: (2018-12-01)

Ausência de interação clopidogrel-estatina em pacientes submetidos a implante de "stent" coronário Ausencia de interacción clopidogrel-estatina en pacientes sometidos a implante de "Stent" coronario Lack of clopidogrel-statin interaction in patients undergoing coronary stent implantation
by: Carlos Vicente Serrano Júnior, et al.
Published: (2010-09-01)

Fate and prodigies in roman religion and literature
by: Peter Kuhlmann
Published: (2011-12-01)

Berman and Livonia – Two Prodigious Strangers
by: Kristjan Oad
Published: (2013-01-01)

Fracture in drug‐eluting stents increases focal intimal hyperplasia in the atherosclerosed rabbit iliac artery
by: Conway, Claire, et al.
Published: (2020)

Association between high on-treatment platelet reactivity to clopidogrel and hepatosteatosis in patients undergoing elective stent implantation
by: Yalçın Velibey, et al.
Published: (2018-07-01)

Effects of fenofibrate on lipid profiles, cholesterol ester transfer activity, and in-stent intimal hyperplasia in patients after elective coronary stenting
by: Mokuno Hiroshi, et al.
Published: (2010-10-01)

Intimal hyperplasia in endarterectomized arteries
by: Chen, Changyi
Published: (2008)

Coronary artery intimal hyperplasia
by: Harmon, Thomas Peter
Published: (2011)

Can doubling the maintenance dose of clopidogrel prevent from early stent thrombosis after the primary percutaneous coronary intervention?
by: Farshad Roghani, et al.
Published: (2011-04-01)

Zebrafish as a prodigious tool in neuropsychiatric research
by: Brindha Durairaj, et al.
Published: (2020-08-01)

Changes of high sensitivity C-reactive protein during clopidogrel therapy in patients undergoing percutaneous coronary intervention
by: Shokoufeh Hajsadeghi, et al.
Published: (2016-01-01)

Changes of High Sensitivity C-Reactive Protein During Clopidogrel Therapy in Patients Undergoing Percutaneous Coronary Intervention
by: Hajsadeghi, et al.
Published: (2015-12-01)

High-maintenance-dose clopidogrel in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis.
by: Yu Chen, et al.
Published: (2013-01-01)

Comparative study of ticagrelor and clopidogrel in therapeutic effect of acute myocardial infarction patients undergoing percutaneous coronary intervention
by: Guangtao Yao, et al.
Published: (2017-12-01)

Study on The Timing of Clopidogrel and The Prognosis of Stent-implanted Patients
by: Yu-ting Chang, et al.
Published: (2007)

Acute myocardial infarction occurring while on chronic clopidogrel therapy ('clopidogrel failure') is associated with high incidence of clopidogrel poor responsiveness and stent thrombosis.
by: Ehud Regev, et al.
Published: (2018-01-01)

Comparing of Light Transmittance Aggregometry and Modified Thrombelastograph in Predicting Clinical Outcomes in Chinese Patients Undergoing Coronary Stenting with Clopidogrel
by: Xiao-Fang Tang, et al.
Published: (2015-01-01)

Cellular aspects of intimal hyperplasia formation
by: Jackson, Andrew John
Published: (2011)

Percutaneous coronary intervention for coronary allograft vasculopathy with drug-eluting stent in Indian subcontinent: Issues in diagnosis and management
by: Mohammed Shakawat Alam, et al.
Published: (2020-01-01)

Efficacy and safety of proton pump inhibitors combined with clopidogrel in patients undergoing percutaneous coronary intervention: a meta-analysis
by: Yao-Yao Han, et al.
Published: (2021-03-01)

Hormesis in Aging and Neurodegeneration—A Prodigy Awaiting Dissection
by: Lei Mao, et al.
Published: (2013-06-01)

Acquiring, encoding, and re-using clinical knowledge in PRODIGY
by: Richard Hall, et al.
Published: (2002-11-01)

Potassium iodide: A prodigy in the treatment of subcutaneous zygomycosis
by: Peela Nalini, et al.
Published: (2019-01-01)

Stepchild or Prodigy? Neuroprotection in Multiple Sclerosis (MS) Research
by: Andrea Rottlaender, et al.
Published: (2015-07-01)

Twelve-month comparative analysis of clinical outcomes using biodegradable polymer–coated everolimus-eluting stents versus durable polymer–coated everolimus-eluting stents in all-comer patients
by: Atul Abhyankar, et al.
Published: (2019-03-01)